Kolumne, ORE

Original-Research: q.beyond AG - von NuWays AG Einstufung von NuWays AG zu q.beyond AG Unternehmen: q.beyond AG ISIN: DE0005137004 Anlass der Studie: Update Empfehlung: BUY seit: 25.01.2024 Kursziel: 1.00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Philipp Sennewald One q.beyond to drive margins in 2024e In light of the ongoing restructuring process as well as macro-headwinds, we observed a rather uninspiring operating performance, especially on the bottom-line, as of 9M '23.

25.01.2024 - 09:02:31

Original-Research: q.beyond AG (von NuWays AG): BUY


Original-Research: q.beyond AG - von NuWays AG

Einstufung von NuWays AG zu q.beyond AG

Unternehmen: q.beyond AG
ISIN: DE0005137004

Anlass der Studie: Update
Empfehlung: BUY
seit: 25.01.2024
Kursziel: 1.00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Philipp Sennewald

One q.beyond to drive margins in 2024e
 
In light of the ongoing restructuring process as well as macro-headwinds,
we observed a rather uninspiring operating performance, especially on the
bottom-line, as of 9M '23. Despite that, q.beyond is seen to achieve its FY
'23 guidance: EUR185-191m sales, EUR 5-7m EBITDA and > EUR -4m FCF. While the
lower end of the sales guidance should be reached (eNuW: EUR 186m) and FCF
generation should even be positive (eNuW: EUR 1.4m), meeting the EBITDA
outlook (eNuW: EUR 5.1m) still depends on a decision by the tax authorities
concerning the Plusnet sale in 2019. The group's operating EBITDA looks set
to come in at only EUR 0.3m (eNuW).
 
That said, the company is seen to publish preliminary FY figures in early
March, (final: March 30th) as well as an initial FY '24 guidance. As
management aims to reap the fruits of the imposed efficiency measures in
connection with the 2025 Strategy, investors should expect an outlook,
targeting sales growth in the mid-to-high-single-digit range (eNuW: +7%;
eCons: +5.4%), positive FCF generation (eNuW: EUR 5.3m; eCons: EUR 3.7m) as
well as EBITDA of EUR 6-9m (eNuW: EUR 6.1m; eCons: EUR 8.1m).
 
As a reminder, with the 2025 Strategy, management set itself three
strategic priorities: (1) Ongoing focus on key verticals (retail, logistics
& manufacturing) coupled with an expansion of the consulting and
development business, (2) effective go-to-market with an increased emphasis
on the indirect sales channels (35% of Q3 order intake) as well as (3) the
continuous implementation of One q.beyond, which is the company's current
efficiency program. Here, the focus is on streamlined processes via the
elimination of duplicate structures, an optimized order-to-cash process and
an increased near-/offshoring share (target: >20% vs c. 10% currently).
 
While some of those measures, such as the improved receivables management,
already took effect (improved FCF guidance (old: > EUR 8m), the
implementation of One q.beyond is seen to fully unfold from 2024e onwards,
thus allowing for expanding margins.
 
We hence turn cautiously optimistic but keep our PT unchanged at EUR 1.00.
While the stock should have downside protection thanks to the EUR 37m net
cash position as well as a land plot in Hamburg (EUR 17m book value), an
upbeat FY guidance in March as well as a strong start into the year (Q1 to
be released on May 8th) could serve as re-rating catalysts. Remains a BUY.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28751.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...